Skip to main content
logo
Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.640
-0.090 (-5.20%)
At close: Aug 26, 2026, 4:00 PM EDT
1.650
+0.010 (0.61%)
Pre-market: Aug 27, 2026, 8:24 AM EDT

Veraxa Biotech AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Aug '26 Dec '24 Dec '23
Market Capitalization
41317-
Market Cap Growth
-87.45%--
Last Close Price
1.6410.02-

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Aug '26 Dec '24 Dec '23
PB Ratio
0.689.25-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Aug '26 Dec '24 Dec '23
Debt / Equity Ratio
0.030.03-
Net Debt / Equity Ratio
-0.14-0.14-0.21
Net Debt / EBITDA Ratio
0.170.170.77
Net Debt / FCF Ratio
0.570.571.51
Quick Ratio
2.172.177.22
Current Ratio
2.202.207.39
Return on Equity (ROE)
-65.29%-65.29%-
Return on Assets (ROA)
-20.46%-20.46%-
Return on Capital Employed (ROCE)
-35.20%-35.20%-18.40%

Yields

Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Aug '26 Dec '24 Dec '23
Earnings Yield
-75.07%-9.80%-
FCF Yield
-23.53%-2.73%-
Buyback Yield / Dilution
--2.36%-
SEC Filings: 10-K · 10-Q